Multi-disciplinary role in an early med-device start-up focussing on non-invasive Continuous Glucose Monitoring.• Led PMO – Defined and implemented lean processes appropriate for a high discovery R&D environment.• Led fundamental Physiology research characterization investigations to reduce technical risk.• Led in-house Cytotox Team and external Biocomp testing.• Led Systems Engineering activities – Requirements Capture, verification protocol drafting and execution.• Internal SME on IEC60601-1 compliance.

Led development efforts for a Disposable wearable physiological monitor as part of the company's Remote Patient Monitoring aims to improve outcomes in COPD.• Led Technical Feasibility for a novel, low-cost, scalable onshore manufacturing approach• Led existing sensor Design Transfer to a Taiwanese offshore manufacturing site• Led a DHF remediation project in-line with FDA Design Controls: Requirements Capture, Design Inputs, Risk management, Design Outputs, Biocompatibility, IEC60601, HF Validation, V&V

Core Team Lead for a disposable patch pump for Type 2 diabetes, originally launching Sep 2018. Achievements:• Led Manufacturing, RA, Marketing and R&D cross functional team to prioritize go-to-market MVP feature set.• Worked with Manufacturing to develop staged strategy that minimized risk and initial capital.• Working with key stakeholders, developed comprehensive financial model including Capex/Opex.• Aligned with Cross functional Senior Management and led Feasibility Exit with agreed residual risk.

Working with marketing and R&D, I planned new-product development roadmaps and led multiple programs: • Developed, CE marked and 2019 limited launch G6+ Enhanced 14day CGM Product, later withdrawn• Led Development of an improved CGM algorithm that increases data availability whilst maintaining accuracy. Included FDA 510(k) submission in compliance with iCGM Special Controls.• Led feasibility and development of Dexcom ONE for overseas markets to leverage existing Capital expenditure

• Led Technical Feasibility of novel CGM technologies to facilitate alternate sites and extended 14 day wear duration.

Chair of the Artificial Pancreas program at the world’s top charity for people with Type 1 Diabetes, Juvenile Diabetes Research Foundation. Working with both Academia and Industry, developed strategy and performed due diligence for viable opportunities, negotiated and closed investment opportunities: • Launched a major initiative to investigate/mitigate insulin infusion set failures, funding multiple research projects, and closing two industry Investment deals - Becton Dickinson & Capillary Biomedical.• Developed an initiative to fill near-term gaps in 1st & 2nd generation closed loop systems by closing Investment deals with Bigfoot Biomedical and TidePool, & developing a pipeline including SFC Fluidics & EOFlow.• Strategize technology pathway for 3rd generation closed loop systems & closed multiple Investments: Pacific Diabetes Technology CGM Infusion Set, Glusense Cell-Based Implantable CGM & Arecor Insulin.

Product Development Consultant at Nemaura Medical Inc & Starfish MedicalAt Nemaura, led early Feasibility of a Non-Invasive glucose monitor for diabetes management: • Requirements capture and technical translation of scientific requirements into verifiable specifications• Developed PMA regulatory and clinical strategy in-line with ISO15197 CLSI CGM guidelinesConsulted at Starfish Medical, Canada’s largest Medical Device only consultancy, working on the following projects:• IEC60601 3rd Ed. Re-Certification of Legacy Battery powered Operating Tables – required new DHF & V&V.• Led Development of a novel Tinnitus treatment iPhone App (DHF, V&V) and 510(k) Predicate Comparison.• Led Development of Patient Interface plastic disposables for a legacy Ventilator modernization project.• Led Development (DHF, V&V) for a novel iPhone based Pulse Oximeter App

Co-Founded & grew a university Start-Up into an ISO13485 certified company with a CE marked product & a pipeline of follow on products:• Core Technology Inventor – Optical Assessment of Peripheral Arterial Disease, publishing journal papers• Fund Raising – Awarded $750k in government grants, secured more than $5MM in equity funding. • Generated & managed IP – Named inventor on multiple patent families in >50 countries.• Technical Architect – led multiple generations of New Product Development (ISO14971 & IEC60601)

A Principal research position developing industrial instrumentation and diagnostic equipment:• Awarded Innovation Fellowship for Black Box technology in the OR.• Developed electro-mechanical Proof of Concept Medical Devices: Pulse Oximetry, Inhaler Cloud Particle Characterization, Cardiovascular compliance modelling.